Additional Independent Research Further Supports Glucose Metabolism as Important COVID-19 Target Jul 29, 2020
Moleculin Announces New Independent In Vitro Testing Confirms Antiviral Activity of WP1122 in Coronavirus Jul 21, 2020
Moleculin Announces Agreement to Produce WP1122 for Expanded Development of Potential COVID-19 and Oncology Drug Candidate Jul 15, 2020
New Publication Finds Combination of WP1066 and Radiation Resulted in Long-Term Survival in Human Brain Tumor Mouse Model Jul 1, 2020
